Skip to main content

Month: April 2026

SRx Health Solutions Acquires Shares of Compass Inc. and Increases Investment in Opendoor Technologies Inc.

SRXH files Form S-4 with SEC in connection with EMJX merger  SRXH provides update on performance through mid-April with an approximate 3.5% gain in hedging pool, driven by EMJX’s algorithm, and an approximate gain of 8% in its long treasury investment holdings NORTH PALM BEACH, Fla., April 16, 2026 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) and EMJ Crypto Technologies (“EMJX”), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced acquiring shares in the open market of Compass Inc. and increasing its investment in Opendoor Technologies Inc. Further to additions to its portfolio, the Company is pleased to report that it has filed a Form S-4 with the Securities and Exchange Commission in connection...

Continue reading

Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress

AGOURA HILLS, Calif., April 16, 2026 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We”), a clinical-stage biopharmaceutical company developing drugs for the treatment of orphan oncology indications, as well as antisense and small molecule injectable drugs for the treatment of cancer, today announced its financial results for the fiscal year ended December 31, 2025 (“FY 2025”), as compared to the fiscal year ended December 31, 2024 (“FY 2024”). The financial results are based on the 2025 Annual Report on Form 10-K (“Form 10-K”) as filed with the Securities and Exchange Commission (“SEC”) on April 15, 2026. The Company recorded net income after tax of approximately $249.0 million, compared to a net loss of approximately $4.8 million in the prior year. The net income was primarily driven...

Continue reading

Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026

Poster presentation scheduled for Tuesday, May 5th at 12:30 PM CDT Denver, CO, April 16, 2026 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today announced that data from its lead program, PALI-2108, has been selected for poster presentation at Digestive Disease Week® (DDW) 2026, taking place May 2–5, 2026 in Chicago. The Company will be in attendance alongside members of its Clinical Advisory Board (CAB), further reinforcing its engagement with leading experts in inflammatory bowel disease as it advances PALI-2108 toward the clinic. Poster Presentation details are as follows: Session Type: Abstract PosterSession Title:...

Continue reading

Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow

TORONTO, April 16, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, will announce its first quarter 2026 financial results after market close on Thursday, May 7, 2026. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. First Quarter 2026 Results Conference Call Details: Date: Thursday, May 7, 2026 Time: 4:30 p.m. ET Live Call Dial-in Numbers: 1-800-717-1738 (North America) or 1-646-307-1865 (International) The call will also be broadcast live and archived here. About Profound Medical Corp. Profound is a commercial-stage medical device...

Continue reading

WeRide and GAC Debut First Co-Developed Vehicle Aion N60 Powered by WRD 3.0

GUANGZHOU, China, April 16, 2026 (GLOBE NEWSWIRE) — GAC Aion today officially launched pre-sales for the Aion N60, a new smart urban SUV powered by WeRide Driving (WeRide WRD* 3.0), WeRide’s one-stage end-to-end ADAS (Advanced Driver Assistance System) solution. The Aion N60 has intelligent driving features across the entire lineup, bringing advanced assisted driving to a broad consumer market. With WeRide WRD 3.0, the Aion N60 delivers full-scenario, full-function ADAS capabilities, covering urban roads, highways, parking, and active and passive safety. This allows for a seamless, end-to-end assisted driving experience designed to support everyday commuting. *Formerly known as WePilotThe Aion N60 powered by WRD 3.0 delivers intelligent driving features across the entire lineup The Aion N60 is the first mass-produced passenger...

Continue reading

Nanox.ARC X Digital Advanced 3D imaging built for access and powered by innovation Wins 2026 Red Dot Award for Product Design

International Red Dot Jury recognizes Nanox.ARC X for design excellence that brings advanced 3D tomosynthesis imaging into a wider range of clinical settings PETACH TIKVA, ISRAEL – 16 April, 2026 – Nanox Imaging Ltd. (“Nanox”, or the “Company”, Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced that its Nanox.ARC X 3D digital tomosynthesis system has been awarded a Red Dot Award: Product Design 2026, recognition from one of the world’s largest and most established design competitions. The Red Dot Jury selected the Nanox.ARC X from a field of thousands of entries submitted by manufacturers and design studios worldwide, recognizing the system for its exceptional product design. The Nanox.ARC X will be featured in the Red Dot Design Yearbook, showcased on the Red Dot website, and presented in the...

Continue reading

GBT Technologies (OTC: GTCH) Appoints Filmmaker Minh Collins as President of Cube X Media Subsidiary

LOS ANGELES, April 16, 2026 (GLOBE NEWSWIRE) — GBT Technologies, Inc. (OTC PINK: GTCH) appointed Minh Collins as President of Cube X Media Corporation, a wholly owned subsidiary of GBT Technologies. Collins, an established film and commercial producer, will lead Cube X Media’s content strategy across digital advertising, vertical video, and cinematic productions that are designed to integrate with the AI-enabled point-of-sale machine network operated by sister subsidiary Cube Wellness Technologies. Key FactsCompany: GBT Technologies, Inc. Ticker: OTC PINK: GTCH Headquarters: Los Angeles, California, United States Subsidiary: Cube X Media Corporation (wholly owned) Sister Subsidiary: Cube Wellness Technologies (wholly owned) Appointment: Minh Collins, President of Cube X Media Effective Date: April 10, 2026 Industry: Artificial...

Continue reading

Airship AI Announces $2.1 Million Firm Fixed Price Brand Name Only Award from Department of Homeland Security

Follow-on Award Reflects Expanding Need for Secure, AI Driven Enterprise Video Intelligence Solutions REDMOND, Wash., April 16, 2026 (GLOBE NEWSWIRE) — Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), a leader in AI-driven video, sensor, and data management surveillance solutions, has been awarded a contract from an agency within the Department of Homeland Security (DHS) for the Company’s AI driven technical solutions supporting public safety and investigative requirements. “This award reflects the continued momentum and critical importance of AI-driven surveillance solutions in advancing public safety and homeland security, especially along the Northern and Southern Borders,” said Paul Allen, President of Airship AI. “As the administration prioritizes strengthening national security, autonomous edge AI-driven...

Continue reading

Diginex Limited (DGNX) Announces US$1.5 Billion AI Acquisition, Adding High Growth Business and Targets $280M Revenue by 2027

Transformational AI Acquisition Accelerates Diginex’s Top Line with High Margin, High Growth Revenues via Expansion into AI Driven Customer Intelligence and Enterprise Agentic Solutions at Scale LONDON, April 16, 2026 (GLOBE NEWSWIRE) — Diginex Limited (“Diginex” or the “Company”) (Nasdaq: DGNX), a leading provider of Sustainability RegTech solutions, today announced that it has signed a definitive Share Purchase Agreement (“SPA”) to acquire Resulticks Global Companies Pte Limited (“Resulticks”), a globally recognized leader in real‑time, AI‑driven customer intelligence solutions, in an all‑share transaction valued at US$1.5 billion, paid in full with Diginex shares at $1.32 per share. Already At Scale – Resulticks delivered CY2025 revenues of ~US$150million with EBITDA of ~US$46million, reflecting a 32% EBITDA margin. Proven...

Continue reading

Thomasville Bancshares, Inc. Announces Earnings, Cash Dividend, and Stock Repurchase Program

THOMASVILLE, Ga., April 16, 2026 (GLOBE NEWSWIRE) — Thomasville Bancshares, Inc. (OTCID: THVB), the parent company of Thomasville National Bank and TNB Financial Services, reported its financial results for the first quarter ended March 31, 2026. The company also announced its Board of Directors approved a cash dividend of $1.50 per share. The dividend will be paid on July 2, 2026, to shareholders of record as of June 12, 2026. In addition, the company announced its board of directors has authorized the company to repurchase up to $5 million of its outstanding common stock. First-Quarter 2026 HighlightsNet Income for the quarter of $12,413,453 compared to $10,503,378 for the same period last year, an increase of 18%. Earnings per share for the quarter were $1.96 (basic) and $1.86 (diluted). Pre-tax pre-provision income of $16.9...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.